<DOC>
	<DOCNO>NCT01026857</DOCNO>
	<brief_summary>The purpose study determine whether Propionyl-L-carnitine administration may ameliorate illness patient affect mild moderate ulcerative colitis already treatment one standard treatment ( corticosteroid exclude ) .</brief_summary>
	<brief_title>Propionyl-L-Carnitine Ulcerative Colitis</brief_title>
	<detailed_description>The trial foresee administration 2 different dosage Propionyl-L-carnitine ( ST261 ) colon release tablet , 1 g/die 2 g/die . The primary objective trial evaluate clinical/endoscopic response define lowering Disease Activity Index ( DAI score ) least 3 point ot reach remission , clinical/endoscopic remission ( DAI score &lt; = 2 individual subscore &gt; 1 ) histological efficacy two combine dosage PLC ( i.e . PLC 1 g/die + 2 g/die ) comparison placebo , define improvement Histological Index ( HI ) least 1 point end study ( final HI score &lt; = 1 defined histological remission ) . The secondary objective evaluate clinical/endoscopic histological efficacy two dosage PLC individually consider comparison Placebo , order gather information dosage use subsequent trial . The safety tolerability regimen study also objectives study .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Have read Information Patient sign Informed Consent Form . Age comprise 18 75 include . If female , pregnant nursing . For woman childbearing potential , willingness avoid pregnancy treatment period least 1 month last dose drug . Availability pancolonoscopy histology confirm diagnosis active ulcerative colitis . Disease Activity Index comprise 3 10 , inclusive , ( mild moderate ulcerative colitis ) . On one follow treatment ulcerative colitis prior baseline visit : 1 . Stable background oral aminosalicylates ( mesalazine , balsalazide , olsalazine ) sulfasalazine therapy great equal 4 week prior baseline assessment . 2 . Stable background mercaptopurine azathioprine great equal 12 week prior baseline assessment . First diagnosis ulcerative colitis . Crohn 's disease . Current previous ( last 10 day precede screen ) use systemic corticosteroid . Use antibiotics last 10 day precede screening . Use NSAID 's last 10 day precede screening . Use probiotics last 10 day precede screen Positive stool culture ( perform , accord Investigator 's judgment , ass possible parasitologic infection ( ) ) . Significantly impaired liver , renal , pulmonary cardiovascular function . History colon resection . Diverticulitis . Diagnosis proctitis Stable rectally administer therapy last 10 day . Active chronic infection ( ) . Simultaneous participation another clinical trial , participation clinical trial involve investigational drug within 3 month enrolment present study . Any physical psychological condition patient could let investigator suspect his/her poor compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>